CranioSense is a clinical stage startup on a mission to unlock the hidden parameters of brain health by enabling on demand neurological insight and treatment across the neurological care spectrum. IPASS (Intracranial Pressure Assessment and Screening System) is the first product that we are bringing to the market to realize that mission, a noninvasive medical device for initial diagnosis and continuous monitoring of intracranial hypertension, the point at which ICP becomes clinically unacceptable.
Company Details
- Employees
- 7
- Founded
- -
- Address
- 175 Great Rd, Bedford,massachusetts 01730,united States
- Industry
- Medical Device
- Website
- http://craniosense.com
- Keywords
- Combat Casualty Care, Physiological Monitoring, Medical Manufacturing, Engineering, Medical Diagnostics, Medical Device, Neurology, Intracranial Pressure, Intracranial Hypertension, Traumatic Brain Injury, Concussion, Non-traumatic Headache, Emergency Department, ICU, Neuro ICU, Idiopathic Intracranial Hypertension.
- HQ
- Bedford, Massachusetts
Craniosense Questions
Craniosense's website is http://craniosense.com
Craniosense's LinkedIn profile is https://www.linkedin.com/company/craniosense
Craniosense has
7 employees.
View email and phone details for 7
employees at Craniosense.
Craniosense's industry is
Medical Device
Craniosense's top competitors are
Somnics, Inc.,
Vonova,
Arsenal Medical,
Ice Neurosystems, Inc.,
Juniper Biomedical,
Lattice Medical,
Neurobionics,
Mybiometry,
Brainspace,
Cellular Vehicles.
Craniosense's categories are Medical Device
Craniosense's founding year is 2022
